CAMBRIDGE, Mass. - Alnylam Pharmaceuticals Inc. said Friday its chief scientific officer, John A. Schmidt Jr., is leaving the company, effective Sept. 30, to pursue other interests.
The company has no immediate plans to replace Schmidt, 58, a spokeswoman said.
However, "we will look opportunistically should an appropriate candidate present him or herself," Alnylam said in a statement.
Shares closed up 80 cents, or 3.6 percent, to $22.92.
No comments:
Post a Comment